These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1505145)

  • 1. Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine.
    Nigrovic V; Banoub M
    Clin Pharmacokinet; 1992 May; 22(5):396-408. PubMed ID: 1505145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atracurium decay and the formation of laudanosine in humans.
    Nigrovic V; Fox JL
    Anesthesiology; 1991 Mar; 74(3):446-54. PubMed ID: 2001023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium.
    Nigrovic V; Gaspari J; Banoub M
    Eur J Clin Pharmacol; 1996; 49(4):325-32. PubMed ID: 8857080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma.
    Welch RM; Brown A; Ravitch J; Dahl R
    Clin Pharmacol Ther; 1995 Aug; 58(2):132-42. PubMed ID: 7648763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of atracurium and laudanosine in the elderly.
    Kent AP; Parker CJ; Hunter JM
    Br J Anaesth; 1989 Dec; 63(6):661-6. PubMed ID: 2611066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.
    Parker CJ; Hunter JM
    Br J Anaesth; 1989 Feb; 62(2):177-83. PubMed ID: 2923767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery.
    Eddleston JM; Harper NJ; Pollard BJ; Edwards D; Gwinnutt CL
    Br J Anaesth; 1989 Nov; 63(5):525-30. PubMed ID: 2605068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU.
    Parker CJ; Jones JE; Hunter JM
    Br J Anaesth; 1988 Nov; 61(5):531-40. PubMed ID: 3207525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics.
    Farenc C; Audran M; Lefrant JY; Mazerm I; Bressolle F
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):117-26. PubMed ID: 10202964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laudanosine (a metabolite of atracurium) increases the minimum alveolar concentration of halothane in rabbits.
    Shi WZ; Fahey MR; Fisher DM; Miller RD; Canfell C; Eger EI
    Anesthesiology; 1985 Dec; 63(6):584-8. PubMed ID: 2932981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients.
    Gwinnutt CL; Eddleston JM; Edwards D; Pollard BJ
    Br J Anaesth; 1990 Dec; 65(6):829-32. PubMed ID: 2265055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage.
    Tassonyi E; Fathi M; Hughes GJ; Chiodini F; Bertrand D; Muller D; Fuchs-Buder T
    Acta Anaesthesiol Scand; 2002 Nov; 46(10):1236-41. PubMed ID: 12421196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of laudanosine, but not of atracurium, are increased during the anhepatic phase of orthotopic liver transplantation in pigs.
    Pittet JF; Tassonyi E; Schopfer C; Morel DR; Mentha G; Fathi M; Le Coultre C; Steinig DA; Benakis A
    Anesthesiology; 1990 Jan; 72(1):145-52. PubMed ID: 2297117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of atracurium and laudanosine in human plasma by high-performance liquid chromatography.
    Varin F; Ducharme J; Besner JG; Théorêt Y
    J Chromatogr; 1990 Aug; 529(2):319-27. PubMed ID: 2229251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg
    Aguilar A; Andaluz A; Moll X; Cristòfol C; García F
    Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of atracurium and laudanosine in dog plasma during cardiopulmonary bypass by high performance liquid chromatography with fluorometric detection].
    Yang Y; Chen M; Kuang Y; Ye L; Zhang W
    Se Pu; 2013 Jun; 31(6):572-6. PubMed ID: 24063198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 51W89: preliminary data.
    Hunter JM; Eastwood NB; Boyd AH; Parker CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():94. PubMed ID: 8533555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atracurium and laudanosine pharmacokinetics in acute renal failure.
    Hunter JM
    Intensive Care Med; 1993; 19 Suppl 2():S91-3. PubMed ID: 8106685
    [No Abstract]   [Full Text] [Related]  

  • 19. Simplified method for the determination of atracurium and laudanosine in pig plasma by high-performance liquid chromatography and fluorimetric detection.
    Schopfer C; Benakis A
    J Chromatogr; 1990 Mar; 526(1):223-7. PubMed ID: 2341536
    [No Abstract]   [Full Text] [Related]  

  • 20. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion.
    Grigore AM; Brusco L; Kuroda M; Koorn R
    Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.